Previous research has consistently shown that B cell-derived GZMB plays a pivotal role in anti-tumor activity, with patients exhibiting a higher proportion of GZMB+ B cells demonstrating improved prognoses (43–45). The gene discussed is GZMB; the disease is neoplasm.